RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
Phase 1/2 Suspended
30 enrolled
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
Phase 2 Suspended
184 enrolled
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
Phase 2 Suspended
42 enrolled
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
Phase 1 Suspended
50 enrolled
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Phase 1/2 Suspended
97 enrolled
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Phase 1 Suspended
30 enrolled
Glioblastoma Remote Monitoring and Care - Research Protocol
Phase NA Suspended
25 enrolled
Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
Phase 1 Suspended
36 enrolled
Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)
Phase NA Suspended
10 enrolled
Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases
Phase NA Suspended
24 enrolled
Surgical Resection of Latent Brain Tumors Prior to Recurrence
Phase NA Suspended
40 enrolled
Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma
Phase 1 Suspended
8 enrolled
68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma
Phase 1 Suspended
24 enrolled
DSOS
Suspended
900 enrolled
ENHANCING
Phase 1 Suspended
30 enrolled
Study of Niacin in Glioblastoma
Phase 1/2 Suspended
59 enrolled
Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology Biopsies
Suspended
285 enrolled
Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma
Phase 2 Suspended
33 enrolled
Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
Phase 1 Suspended
10 enrolled
LAMB-G
Suspended
40 enrolled
Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial
Phase 1 Suspended
67 enrolled
Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)
Phase 2 Suspended
10 enrolled
A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)
Phase 2 Suspended
1 enrolled
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors
Suspended
300 enrolled
Investigational Imaging Technique During Brain Surgery
Phase NA Suspended
24 enrolled
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
Suspended
100 enrolled
SONOFLUO
Phase NA Suspended
134 enrolled
FUN
Phase NA Suspended
50 enrolled
GAMMA
Phase NA Suspended
72 enrolled